Combination of PI3K/mTOR Inhibition Demonstrates Efficacy in Human Chordoma
|
|
- Elwin Clark
- 5 years ago
- Views:
Transcription
1 Combination of PI3K/mTOR Inhibition Demonstrates Efficacy in Human Chordoma JOSEPH SCHWAB 1, CRISTINA ANTONESCU 2, PATRICK BOLAND 3, JOHN HEALEY 3, ANDREW ROSENBERG 4, PETUR NIELSEN 4, JOHN IAFRATE 4, THOMAS DELANEY 5, SAM YOON6, EDWIN CHOY 7, DAVID HARMON 7, KEVIN RASKIN 1, CAO YANG 1, HENRY MANKIN 1, DEMPSEY SPRINGFIELD 1, FRANCIS HORNICEK 1 and ZHENFENG DUAN 1 1 Department of Orthopedic Surgery, Section of Orthopedic Oncology, Sarcoma Research Laboratory, 4 Department of Pathology, 5 Department of Radiation Oncology, 6 Department of Surgery, Section of Surgical Oncology and 7 Department of Medical Oncology, Massachusetts General Hospital, Boston, MA; 2 Department of Pathology, and 3 Department of Surgery, Section of Orthopedic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A. Abstract. Background: Chordomas are rare tumors of the axial skeleton for which surgical resection remains the most reliable means of cure. PI-103 is a inhibitor of PI3K/AKT and mtor activation. This study aims to determine whether the PI3K/mTOR pathway was active in chordomas and whether their inhibition could lead to decreased proliferation and increased apoptosis. Materials and Methods: Thirteen human chordoma were tested for activation of the PI3K/mTOR pathway. The human chordoma cell line UCH-1 was treated with increasing doses of PI-103. Inhibition of AKT and mtor was examined and assays assessing proliferation and apoptosis were performed. Results: The chordoma specimen demonstrated activation of the PI3K/mTOR pathway. PI-103 inhibited the AKT and mtor activation in the UCH-1 cell line. PI-103 inhibited proliferation and induced apoptosis in UCH-1. Conclusion: The PI3K/AKT and mtor signaling pathway is constitutively activated in chordoma. PI-103 decreases proliferation and induces apoptosis in the UCH-1 via inhibition of the PI3K/mTOR pathway. The advent of targeted molecular therapy has fostered hope for new systemic therapies against historically chemo-resistant tumors such as chordomas. Unfortunately, the molecular pathogenesis of chordomas is poorly understood. While radiation Correspondence to: Joseph H. Schwab, MD, MS Department of Orthopedic Surgery, Section of Orthopedic Oncology, Sarcoma Research Laboratory, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, U.S.A. Tel: , jhschwab@partners.org Key Words: Chordoma, mtor, PI3K, PI-103. therapy has been shown to be a useful adjuvant in chordoma (1), complete surgical resection remains the most reliable means of obtaining a cure (2, 3). However, complete surgical excision is difficult and local recurrence rates of over 40% are common (2). Furthermore, there are no proven systemic agents available in cases of distant metastasis, which occurs in 1 out of every 3 patients (2-5). Improved systemic therapies are needed to treat this relatively chemoresistant tumor. There is increasing interest in using targeted therapies for treating chordomas. One study reported an objective radiological response in six cases of recurrent chordoma treated with imatinib mesylate (Gleevec, Novartis) (6). The authors attributed the response to inhibition of the platelet derived growth factor-β receptor (PDGFR-β) which they demonstrated to be phosphorylated. PDGFR-β transmits its message through phosphatidylinositol-3,4,5-trisphosphate (PIP3) via AKT and mtor phosphorylation. The PI3K/AKT/mTOR pathway suppresses apoptosis, promotes cell growth and drives cellular proliferation. Abnormalities in the PI3K/AKT/mTOR pathway have been implicated in many forms of cancer (7, 8). Inhibition of the mtor signaling pathway with rapamycin has been shown to be an effective means of treating many tumors in vitro and in vivo (9). Problems with the solubility and stability of rapamycin have lead some to pursue analogs of this agent (9). While many of these mtor inhibitors will soon be available clinically, it remains to be seen whether highly selective inhibitors will have clinical efficacy. Several highly selective molecular inhibitors have had disappointing clinical results in spite of impressive pre-clinical results (10). In addition, some authors have attributed the success of other targeted therapies to their ability to inhibit more than one target (11). Furthermore, selective inhibition of mtor has been shown to have the paradoxical /2009 $
2 Figure 1. Western blot of key downstream components of PI3K/AKT/mTOR signaling pathway. The first column contains a gastrointestinal stromal tumor and it is intended as a control. The following 13 columns contain proteins extracted from human chordoma tissue after surgical resection. The Western blot demonstrates the activity of the PI3K/AKT/mTOR signaling in the majority of surgically excised chordomas. effect of activating AKT via the dis-inhibition of upstream mechanisms (12). For these reasons targeted therapy is moving towards utilizing more than one selective inhibitor or inhibitors with more than one target. PI-103 is an agent that has been shown to inhibit the growth of glioma cells and leukemia cells through its inhibition of both PIP3 and mtor (12). The goals of this study were to determine whether the PI3K/mTOR pathway was active in human chordoma, and also to discern whether inhibition of PI3K/mTOR by PI-103 could affect proliferation and apoptosis in a chordoma cell line. Materials and Methods Human chordoma tissue. Thirteen surgically treated patients diagnosed with chordoma were identified and utilized for the study under an IRB approved protocol. Tissue specimens obtained for protein analysis were maintained at 70 C by the tissue procurement service. All diagnoses were confirmed by histological review of Hematoxylin and Eosin stained sections. The histological diagnosis of chordoma is based on sheets and cords of cells in a myxoid stroma. The cells often have a vacuolated, so-called physiliferous, appearance. Specimens with chondroid differentiation were excluded. Cell line. UCH-1 cell line is an established chordoma cell line generously supplied by Dr. Bruderlein of Ulm, Germany (13). The cell line was cultured in RPMI-1740 supplemented with 10% fetal bovine serum, 100 units/ml of penicillin and 100 μg/ml of streptomycin (All purchased from Invitrogen, Carlsbad, CA, USA). The cells were grown on collagen-coated (Collagen Type I Rat Tail, BD Biosciences, Bedford, MA, USA) flasks, and incubated at 37 C with 5% CO 2. PI-103 (3-(4-(4-morpholinyl)pyrido[3,2 :4,5]furo[3,2-d]pyrimidin- 2-yl]phenol) was purchased from EMD chemicals, Inc. (Gibbstown, NJ, USA) and dissolved in DMSO. Chordoma tissue Western blotting. Western blotting was carried out on 13 chordoma samples. Whole cell lysate of the tumor was prepared by grinding 1 g of snap frozen tumor tissue, using a PowerGen 700 Homogenizer (Omni International, Marietta, GA, USA). The ground tissue was resuspended in Radio-Immunoprecipitation Assay (RIPA) lysis buffer (Upstate Biotechnology, Lake Placid, NY, USA) containing a cocktail of protease and phosphatase inhibitors (Sigma, St. Louis, MO, USA), sodium fluoride, sodium orthovanadate and phenylmethylsulfonyl fluoride (PMSF). Protein concentrations were determined using the Bio-Rad protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). Electrophoresis and immunoblotting was performed on the protein extracts using the standard protocol, using 50 μg of protein per sample. Antibodies tested on the immunoblots included: mouse anti-actin (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), anti-phospho-akt (Th 308), anti-akt, antiphospho-mtor (Ser2448), anti-mtor, anti-phospho-pdk1(ser241), anti-pdk1, anti-phospho-s6 ribosomal protein (Ser235/236) and anti- S6 ribosomal protein (Cell Signaling Technology, Inc., Danvers, MA, USA). The secondary antibodies used included Donkey-anti-mouse secondary (Santa Cruz) and anti-rabbit (Calbiochem, La Jolla, CA, USA). Following hybridization with the secondary antibody, the blots 1868
3 Schwab et al: PI3k/mTOR Inhibition and Chordoma were incubated with Immun-Star horseradish peroxidase luminal/ enhancer (Bio-Rad) and exposed onto Kodak Biomax MR Film (Eastman Kodak Company, Rochester, NY, USA). UCH-1 cell line Western blot. The rabbit polyclonal antibodies to mtor, p-mtor, AKT, p-akt and p-stat3 were purchased from Cell Signaling Technologies (Cambridge, MA, USA). The mouse monoclonal antibody to actin was from Sigma-Aldrich. The Brachyury rabbit antibody was from Santa Cruz Biotechnology Inc. Goat anti-rabbit-hrp and goat anti-mouse-hrp were purchased from Bio-Rad. SuperSignal West Pico Chemiluminescent Substrate was purchased from PIERCE (Rockford, IL, USA). Total UCH-1 cell lysates were prepared, and Western blot analysis was performed as previously described (14). Briefly, the UCH-1 cells were lysed in 1X RIPA lysis buffer (Upstate Biotechnology, Charlottesville, VA, USA) and protein concentration was determined by the DC Protein Assay (Bio-Rad). Twenty-five micrograms of total protein were resolved on NuPage 4-12% Bis-Tris Gels (Invitrogen) and immunoblotted with specific antibodies. Primary antibodies were incubated in TBS (ph 7.4) with 0.1% Tween-20 with gentle agitation overnight at 4 C. Horseradish peroxidase (HRP)- conjugated secondary antibodies (Bio-Rad) were incubated in TBS (ph 7.4) with 5% nonfat milk (Bio-Rad) and 0.1% Tween-20, at a 1:2000 dilution for one hour at room temperature with gentle agitation. Positive immunoreactions were detected by using SuperSingal West Pico Chemiluminescent Substrate. Cytotoxicity assay. PI-103 and chemotherapy drug cytotoxicity was assessed in vitro via CellTiter 96 AQ ueous One Solution Cell Cytotoxicity Assay (Promega, Madison, WI, USA). Briefly, cells per well were plated in 96-well plates in culture medium (RPMI-1640 supplemented with 10% fetal bovine serum and penicillin/ streptomycin) containing increasing concentrations of PI-103 chemotherapy drug such as cisplatin or doxorubicin. After 6 days of culture, 20 μl of CellTiter 96 AQ ueous One Solution Cell reagent were added to each well and the plates were incubated for 4 h at 37 C. The resulting absorbance at a wavelength of 490 nm (A490) was read on a SPECTRAmax Microplate Spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). Dose-response curves were fitted with use of GraphPad PRISM 4 software (GraphPad Software, San Diego, CA, USA). Apoptosis assay. Quantification of apoptosis in UCH-1 was also evaluated using the M30-Apoptosense ELISA assay kit, as per manufacturer s instructions (Peviva AB, Bromma, Sweden) (15). UCH- 1 cells were seeded at 8,000 cells/per well in a 96-well plate for 24 hours before treatment with 1 μm PI-103, 1 μm doxorubicin, 10 μm cisplatin or a combination of either of the cytotoxics and PI-103 for an additional 24 hours. The cells were then lysed by adding 10 μl 10% NP-40 per well, and the manufacturer s instructions for the apoptosis assay were then followed. Results PI3K/AKT/mTOR pathway activation in human chordoma. Western blot analysis of 13 samples obtained from surgically resected human chordomas demonstrated positive staining for key components of the PI3K/AKT/mTOR signaling cascade (Figure 1). Both phosphorylated and total PDK, AKT, mtor Figure 2. Western blot of UCH-1 cell line with increasing concentrations of PI-103 (0, 0.01 μm, 0.05 μm, 0.1 μm, 0.5 μm, 1 μm and 5 μm). Note the inhibition of both phosphorylated AKT and mtor, as well as the inhibition of Bcl-X. UCH-1 was positive for Brachyury which is used as one marker for chordomas. and S6 were expressed in the majority of specimens. Figure 1 displays the results of 13 chordoma samples with one human KIT sample serving as a control. AKT and mtor in human chordoma cell line inhibition by PI Western blot analysis of human chordoma cell line UCH- 1 demonstrated that PI-103 inhibited the phosphorylation of both AKT and mtor in a dose-dependent manner (Figure 2). In addition, the anti-apoptosis protein BcL-XL was also inhibited by PI-103. Stat 3 was not inhibited by PI-103 at the doses given. Brachyury is used as a surrogate marker for chordomas and it was positive in the UCH-1 cell line. PI-103 inhibits proliferation of the UCH-1 human chordoma cell line. UCH-1 proliferation was diminished after exposure to PI-103 (Figure 3). Cell proliferation was determined by CellTiter (96 Aq ueous ) One Solution Proliferation Assay. The absorbance was read at 490 nm using a SPECTRAmax Microplate Spectrophotometer reader. PI-103-induced apoptosis in UCH-1. PI-103 induced apoptosis in the UCH-1 (Figure 4). After exposure to 5 μm PI-103, over 50% of the UCH-1 cells underwent apoptosis. The level of apoptosis continued to increase with 10 μm PI-103. PI-103-induced apoptosis with doxorubicin and cisplatin. To further confirm the role of AKT/mTOR in chordoma cells, the effect PI-103 had on apoptosis in cells treated with doxorubicin and cisplatin was evaluated. The addition of PI-103 to UCH-1 cells exposed to either doxorubicin or cisplatin resulted in at 1869
4 Figure 3. mtor/akt inhibitor PI-103 inhibits chordoma UCH-1 cell proliferation. UCH-1 cells were treated with different concentrations of PI-103 in 96-well plates for 6 days. Cell proliferation was determined by CellTiter (96 Aq ueous ) One Solution Proliferation Assay. The absorbance was read at 490 nm using a SPECTRAmax Microplate Spectrophotometer reader. least additive apoptosis. Cytotoxicity assay demonstrated that PI-103 had at least an additive effect on cisplatin- and doxorubicin-induced cell death (Figure 5). Discussion The data support the PI-103 targeting of the PI3K/AKT/mTOR signaling pathway in chordoma. Key downstream proteins within the PI3K/AKT/mTOR pathway were shown to be phosphorylated in the human samples tested including PDK, AKT, mtor and S6. In addition, it was shown that inhibiting key aspects of the PI3K/AKT/mTOR signaling pathway, specifically PI3K and mtor, with PI-103 inhibited the proliferation of a human-derived chordoma cell line (UCH-1). Furthermore, PI-103 induced apoptosis in UCH-1. The induction of apoptosis was increased with the addition of both doxorubicin and cisplatin. Inhibition of both the PI3K and mtor pathways has been shown to be important in human glioma cells with regard to cell growth where selective inhibition of the PI3K moiety did not affect a change in proliferation (12). Fan et al. tested multiple agents with the ability to selectively inhibit class IA PI3Ks including p110α, p110β and p110δ. None of the selective PI3K inhibitors were able to slow proliferation. PI- 103 was shown to inhibit both p110α and mtor, and it was the only compound in their study capable of decreasing proliferation and increasing apoptosis. The mtor protein is known to be activated by growth factor stimulation via class 1A PI3Ks. Another means by which mtor activation occurs is via nutrient stimulation by class 3 PI3Ks (16, 17). Therefore, inhibition of only the class 1A PI3Ks do not prevent mtor activation via the nutrient pathway. Figure 4. PI-103 induces apoptosis in chordoma cell line UCH-1. UCH-1 cells were exposed to incremental doses of PI-103 (0.1 μm, 1 μm, 5 μm and 10 μm). An increase in apoptosis was detected at 1 μm and increased with increased doses of PI-103. Furthermore, inhibition of the mtor pathway alone has been shown to lead to PI3K activation (18). Therefore, inhibition of mtor alone may paradoxically lead to the activation of mtor via the disinhibition of PI3K. For this reason, it is important to consider inhibition of mtor and PI3K when targeting the PI3K/AKT/mTOR pathway. The compound PI- 103 effectively limits proliferation of a human chordoma cell line likely through its dual inhibitory effect on the P110α PI3K and mtor. PI-103 induced apoptosis in the UCH-1 cell line at least in an additive fashion with doxorubicin and cisplatin. Neither doxorubicin nor cisplatin have been shown to be effective in human chordomas. The effect of PI-103/doxorubicin and PI- 103/cisplatin in human chordoma deserves further study. In conclusion, the PI3K/AKT/mTOR pathway is active within human chordomas based on Western blot analysis of 13 surgical specimens. PI-103 decreased proliferation and induced apoptosis in the UCH-1 human chordoma cell line. The apoptotic effects of PI-103 were augmented by doxorubicin and cisplatin. PI-103 deserves further study as a systemic therapy in human chordoma. References 1 Park LD, Liebsch N, Hornicek F, Goldberg S, Mankin H, Rosenberg A, Rosenthal D and Suit H: Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int. J Radiation Oncology Biol Phy 65(5): ,
5 Schwab et al: PI3k/mTOR Inhibition and Chordoma Figure 5. PI-103 induces apoptosis in a synergistic manner with doxorubicin and cisplatin. UCH-1 Human chordoma cell lines were exposed to doxorubicin 1 μm, cisplatin 10 μm and PI μm as single agents. In addition, UCH-1 was exposed to combinations of doxorubicin/pi-103 as well as cisplatin/pi-103. The combination caused a synergistic increase in the level of apoptosis. 2 Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY and Sim FH: Operative management of sacral chordoma. J Bone Joint Surg Am 87(10): , Samson IR, Springfield DS, Suit HD and Mankin HJ: Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg Am 75(10): , Higinbotham NL, Phillips RF, Farr HW and Hustu HO: Chordoma. Thirty-five-year study at Memorial Hospital. Cancer 20(11): , Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W and Meis- Kindblom JM: Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88(9): , Casali PG, Messina A and Stacchiotti S: Imatinib mesylate in chordoma. Cancer 101(9): , Helman LJ and Meltzer P: Mechanisms of sarcoma development. Nat Rev Cancer 3(9): , Hill MM and Hemmings BA: Inhibition of protein kinase B/Akt. implications for cancer therapy. Pharmacol Ther 93(2-3): , Wan X and Helman LJ: The biology behind mtor inhibition in sarcoma. Oncologist 12(8): , Krause DS and Van Etten RA: Tyrosine kinases as targets for cancer therapy. N Engl J Med 353(2): , Fabian MA, Biggs WH 3rd and Treiber DK: A small moleculekinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23(3): , Fan QW, Knight ZA and Goldenberg DD: A dual PI3 kinase/mtor inhibitor reveals emergent efficacy in glioma. Cancer Cell 9(5): , Scheil S, Bruderlein S and Liehr T: Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32(3): , Duan Z, Lamendola DE, Yusuf RZ, Penson RT, Preffer FI and Seiden MV: Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res 22(4): , Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC and Linder S: Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102(1): , Byfield MP, Murray JT and Backer JM: hvps34 is a nutrientregulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 280(38): , Nobukuni T, Joaquin M and Roccio M: Amino acids mediate mtor/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102(40): , Hay N: The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8(3): , Received November 5, 2008 Revised March 9, 2009 Accepted April 21,
Islet viability assay and Glucose Stimulated Insulin Secretion assay RT-PCR and Western Blot
Islet viability assay and Glucose Stimulated Insulin Secretion assay Islet cell viability was determined by colorimetric (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay using CellTiter
More informationEffect of Taurine on Acinar Cell Apoptosis and Pancreatic Fibrosis in Dibutyltin Dichloride-induced Chronic Pancreatitis
212 66 4 329334 Effect of Taurine on Acinar Cell Apoptosis and Pancreatic Fibrosis in Dibutyltin Dichloride-induced Chronic Pancreatitis a,c a* b b a a b a a b c 33 66 4 ʼ 6 6 6 28 6 5 5 5 28 45 ʼ ʼ ʼ
More informationProtocol for Gene Transfection & Western Blotting
The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation
More informationSupplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION
Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION X. Shawn Liu 1, 3, Bing Song 2, 3, Bennett D. Elzey 3, 4, Timothy L. Ratliff 3, 4, Stephen F. Konieczny
More informationHCC1937 is the HCC1937-pcDNA3 cell line, which was derived from a breast cancer with a mutation
SUPPLEMENTARY INFORMATION Materials and Methods Human cell lines and culture conditions HCC1937 is the HCC1937-pcDNA3 cell line, which was derived from a breast cancer with a mutation in exon 20 of BRCA1
More informationSupporting Information
Supporting Information Pang et al. 10.1073/pnas.1322009111 SI Materials and Methods ELISAs. These assays were performed as previously described (1). ELISA plates (MaxiSorp Nunc; Thermo Fisher Scientific)
More informationMTC-TT and TPC-1 cell lines were cultured in RPMI medium (Gibco, Breda, The Netherlands)
Supplemental data Materials and Methods Cell culture MTC-TT and TPC-1 cell lines were cultured in RPMI medium (Gibco, Breda, The Netherlands) supplemented with 15% or 10% (for TPC-1) fetal bovine serum
More informationSupplementary data Supplementary Figure 1 Supplementary Figure 2
Supplementary data Supplementary Figure 1 SPHK1 sirna increases RANKL-induced osteoclastogenesis in RAW264.7 cell culture. (A) RAW264.7 cells were transfected with oligocassettes containing SPHK1 sirna
More informationThe Schedule and the Manual of Basic Techniques for Cell Culture
The Schedule and the Manual of Basic Techniques for Cell Culture 1 Materials Calcium Phosphate Transfection Kit: Invitrogen Cat.No.K2780-01 Falcon tube (Cat No.35-2054:12 x 75 mm, 5 ml tube) Cell: 293
More informationRayBio KinaseSTAR TM Akt Activity Assay Kit
Activity Assay Kit User Manual Version 1.0 March 13, 2015 RayBio KinaseSTAR TM Akt Activity Kit Protocol (Cat#: 68AT-Akt-S40) RayBiotech, Inc. We Provide You With Excellent Support And Service Tel:(Toll
More informationData Sheet TIGIT / NFAT Reporter - Jurkat Cell Line Catalog #60538
Data Sheet TIGIT / NFAT Reporter - Jurkat Cell Line Catalog #60538 Background: TIGIT is a co-inhibitory receptor that is highly expressed in Natural Killer (NK) cells, activated CD4+, CD8+ and regulatory
More informationSUPPLEMENTARY INFORMATION
Supplementary Figures Supplementary Figure S1. Binding of full-length OGT and deletion mutants to PIP strips (Echelon Biosciences). Supplementary Figure S2. Binding of the OGT (919-1036) fragments with
More informationAnalyses of Intravesicular Exosomal Proteins Using a Nano-Plasmonic System
Supporting Information Analyses of Intravesicular Exosomal Proteins Using a Nano-Plasmonic System Jongmin Park 1, Hyungsoon Im 1.2, Seonki Hong 1, Cesar M. Castro 1,3, Ralph Weissleder 1,4, Hakho Lee 1,2
More informationNF-κB p65 (Phospho-Thr254)
Assay Biotechnology Company www.assaybiotech.com Tel: 1-877-883-7988 Fax: 1-877-610-9758 NF-κB p65 (Phospho-Thr254) Colorimetric Cell-Based ELISA Kit Catalog #: OKAG02015 Please read the provided manual
More informationEssential Medium, containing 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Huvec were cultured in
Supplemental data Methods Cell culture media formulations A-431 and U-87 MG cells were maintained in Dulbecco s Modified Eagle s Medium. FaDu cells were cultured in Eagle's Minimum Essential Medium, containing
More informationProduct Manual. [pser 473/474 ]Akt1/2 ELISA kit TABLE OF CONTENTS
[pser 473/474 ]Akt1/2 ELISA kit Catalog # ADI-900-162 96 well enzyme-linked immunoassay kit For use with cell lysates All reagents, except standard, should be stored at 4 C. Store standard at -20 C. Check
More informationTECHNICAL BULLETIN. Catalog Number RAB0447 Storage Temperature 20 C
Phospho-Stat3 (ptyr 705 ) and pan-stat3 ELISA Kit for detection of human, mouse, or rat phospho-stat3 (ptyr 705 ) and pan-stat3 in cell and tissue lysates Catalog Number RAB0447 Storage Temperature 20
More informationTECHNICAL BULLETIN. Phospho-Akt (pser 473 ) ELISA Kit for detection of human, mouse, or rat phospho-akt (pser 473 ) in cell and tissue lysates
Phospho-Akt (pser 473 ) ELISA Kit for detection of human, mouse, or rat phospho-akt (pser 473 ) in cell and tissue lysates Catalog Number RAB0011 Storage Temperature 20 C TECHNICAL BULLETIN Product Description
More informationK-LISA mtor Activity Kit Cat. No. CBA055
User Protocol CBA055 Rev. 20 December 2006 JSW Page 1 of 8 K-LISA mtor Activity Kit Cat. No. CBA055 Note that this user protocol is not lot-specific and is representative of the current specifications
More informationData Sheet. PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002
Data Sheet PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002 DESCRIPTION: The PCSK9[Biotinylated]-LDLR Binding Assay Kit is designed for screening and profiling purposes. PCSK9 is known to function
More informationHuman PKA (Protein Kinase A) Activity Assay Kit
Human PKA (Protein Kinase A) Activity Assay Kit CATALOG NO: IRAAKT2532 LOT NO: SAMPLE INTENDED USE The PKA (Protein Kinase A) Activity kit is designed to quantitatively measure PKA activity in a variety
More informationSTAT3 (py705)/ Pan STAT3 (Human/Mouse/Rat) ELISA Kit
STAT3 (py705)/ Pan STAT3 (Human/Mouse/Rat) ELISA Kit Catalog Number KA2176 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Principle of the Assay...
More informationSUPPLEMENT. Materials and methods
SUPPLEMENT Materials and methods Cell culture and reagents Cell media and reagents were from Invitrogen unless otherwise indicated. Antibiotics and Tet-certified serum were from Clontech. In experiments
More informationOnline Data Supplement. Anti-aging Gene Klotho Enhances Glucose-induced Insulin Secretion by Upregulating Plasma Membrane Retention of TRPV2
Online Data Supplement Anti-aging Gene Klotho Enhances Glucose-induced Insulin Secretion by Upregulating Plasma Membrane Retention of TRPV2 Yi Lin and Zhongjie Sun Department of physiology, college of
More informationFocus Application. Compound-Induced Cytotoxicity
xcelligence System Real-Time Cell Analyzer Focus Application Compound-Induced Cytotoxicity Featured Study: Using the Time Resolving Function of the xcelligence System to Optimize Endpoint Viability and
More informationFigure S1. Generation of inducible PTEN deficient mice and the BMMCs (A) B6.129 Pten loxp/loxp mice were mated with B6.
Figure S1. Generation of inducible PTEN deficient mice and the BMMCs (A) B6.129 Pten loxp/loxp mice were mated with B6.129-Gt(ROSA)26Sor tm1(cre/ert2)tyj /J mice. To induce deletion of the Pten locus,
More informationHIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual)
HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual) BACKGROUND Human Immunodeficiency Virus ( HIV ) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to
More informationValidation & Assay Performance Summary
Validation & Assay Performance Summary LanthaScreen IGF-1R GripTite Cells Cat. no. K1834 Modification Detected: Phosphorylation of Multiple Tyr Residues on IGF-1R LanthaScreen Cellular Assay Validation
More informationValidation & Assay Performance Summary
Validation & Assay Performance Summary CellSensor DBE-bla MDA-MB-468 Cell Line Cat. no. K1814 Pathway Description The phosphatidylinositol-3-kinase (PI3K) signaling cascade is essential for cell growth
More informationSupplementary Information
Supplementary Information Supplementary Figure 1. CD4 + T cell activation and lack of apoptosis after crosslinking with anti-cd3 + anti-cd28 + anti-cd160. (a) Flow cytometry of anti-cd160 (5D.10A11) binding
More informationGeneral Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:
General Laboratory methods Plasma analysis: Plasma insulin (Mercodia, Sweden), leptin (duoset, R&D Systems Europe, Abingdon, United Kingdom), IL-6, TNFα and adiponectin levels (Quantikine kits, R&D Systems
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationHuman Apolipoprotein A1 EIA Kit
A helping hand for your research Product Manual Human Apolipoprotein A1 EIA Kit Catalog Number: 83901 96 assays 1 Table of Content Product Description 3 Assay Principle 3 Kit Components 3 Storage 4 Reagent
More informationp47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO
Supplementary Information p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO Yuri Shibata, Masaaki Oyama, Hiroko Kozuka-Hata, Xiao Han, Yuetsu Tanaka,
More informationTFEB-mediated increase in peripheral lysosomes regulates. Store Operated Calcium Entry
TFEB-mediated increase in peripheral lysosomes regulates Store Operated Calcium Entry Luigi Sbano, Massimo Bonora, Saverio Marchi, Federica Baldassari, Diego L. Medina, Andrea Ballabio, Carlotta Giorgi
More informationSynthesis of Substituted 2H-Benzo[e]indazole-9-carboxylate as Potent Antihyperglycemic Agent that May Act through IRS-1, Akt and GSK-3β Pathways
Electronic Supplementary Material (ESI) for MedChemComm. This journal is The Royal Society of Chemistry 2016 Supplementary Data Synthesis of Substituted 2H-Benzo[e]indazole-9-carboxylate as Potent Antihyperglycemic
More informationSUPPLEMENTAL MATERIALS AND METHODS. Puromycin-synchronized metabolic labelling - Transfected HepG2 cells were depleted of
SUPPLEMENTAL MATERIALS AND METHODS Puromycin-synchronized metabolic labelling - Transfected HepG2 cells were depleted of cysteine and methionine and then treated with 10 μm puromycin in depletion medium
More informationSUPPLEMENTARY INFORMATION. Supplementary Figures S1-S9. Supplementary Methods
SUPPLEMENTARY INFORMATION SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane Jian Huang 1,2#, Jie Yan 1,2#, Jian Zhang 3#, Shiguo Zhu 1, Yanli Wang
More informationSTAT1 (ps727) (Human/Mouse) ELISA Kit
STAT1 (ps727) (Human/Mouse) ELISA Kit Catalog Number KA2171 96 assays Version: 01 Intended for research use only www.abnova.com I. INTRODUCTION STAT1 (ps727) (Human/Mouse) ELISA (Enzyme-Linked Immunosorbent
More informationSTAT3 (py705) (Human/Mouse/Rat) ELISA Kit
STAT3 (py705) (Human/Mouse/Rat) ELISA Kit Catalog Number KA2175 96 assays Version: 01 Intended for research use only www.abnova.com I. INTRODUCTION STAT3 (py705) (Human/Mouse/Rat) ELISA (Enzyme-Linked
More informationA dual PI3 kinase/mtor inhibitor reveals emergent efficacy in glioma
Supplemental data A dual PI3 kinase/mtor inhibitor reveals emergent efficacy in glioma Qi-Wen Fan, Zachary A. Knight, David D. Goldenberg, Wei Yu, Keith E. Mostov, David Stokoe, Kevan M. Shokat, and William
More informationArgininosuccinate synthetase 1 suppression and arginine restriction inhibit cell
Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines Yan-Shen Shan 1, Hui-Ping Hsu 1, Ming-Derg Lai 2,3, Meng-Chi Yen 2,4, Wei-Ching Chen
More informationProthrombin (Human) ELISA Kit
Prothrombin (Human) ELISA Kit Catalog Number KA0496 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationFOXO Reporter Kit PI3K/AKT Pathway Cat. #60643
Data Sheet FOXO Reporter Kit PI3K/AKT Pathway Cat. #60643 Background The PI3K/AKT signaling pathway is essential for cell growth and survival. Disruption of this pathway or its regulation has been linked
More informationRayBio Human, Mouse and Rat Phospho-NF-kB P65 (Ser536) and Total NF-kB P65 ELISA Kit
RayBio Human, Mouse and Rat Phospho-NF-kB P65 (Ser536) and Total NF-kB P65 ELISA Kit Catalog #: PEL-NFKBP65-S536-T User Manual Last revised October 10, 2017 Caution: Extraordinarily useful information
More informationBerberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through mir-93/ PTEN/Akt Signaling Pathway
Chen Accepted: et al.: February Berberine 24, Sensitizes 2015 Ovarian Cancer Cells to Cisplatin www.karger.com/cpb 956 1421-9778/15/0363-0956$39.50/0 Original Paper This is an Open Access article licensed
More informationSupplementary Table; Supplementary Figures and legends S1-S21; Supplementary Materials and Methods
Silva et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability Supplementary Table; Supplementary Figures and legends S1-S21; Supplementary
More informationHuman Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set
Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set Catalog Number : SEK11695 To achieve the best assay results, this manual must be read carefully before using this product
More information1. Materials and Methods 1.1 Animals experiments process The experiments were approved by the Institution Animal Ethics Committee of Jilin University
1. Materials and Methods 1.1 Animals experiments process The experiments were approved by the Institution Animal Ethics Committee of Jilin University (Reference NO. 2015-003). 96 Kunming (KM) mice (8 weeks;
More informationCell Lysis Buffer. Catalog number: AR0103
Cell Lysis Buffer Catalog number: AR0103 Boster s Cell Lysis Buffer is a ready-to-use Western blot related reagent solution used for efficient extraction of total soluble protein in nondenatured state
More informationSupplementary Material for
Supplementary Material for Parathyroid Hormone Signaling through Low-density-lipoprotein-related Protein 6 Mei Wan, Chaozhe Yang, Jun Li, Xiangwei Wu, Hongling Yuan, Hairong Ma, Xi He, Shuyi Nie, Chenbei
More informationFocus Application. Compound-Induced Cytotoxicity
xcelligence System Real-Time Cell Analyzer Focus Application Compound-Induced Cytotoxicity For life science research only. Not for use in diagnostic procedures. Featured Study: Using the Time Resolving
More informationTSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet
Website: thermofisher.com Customer Service (US): 1 800 955 6288 ext. 1 Technical Support (US): 1 800 955 6288 ext. 441 TSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet Details
More informationChemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic
Chemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic Reticulum Stress Lokesh Makhija, BE, Veda Krishnan, MSc, Rakhshinda Rehman, MTech, Samarpana Chakraborty, MSc, Shuvadeep Maity,
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL Table S1. Primers and fluorescent probes used for qrt-pcr analysis of relative expression levels of PPP family phosphatases. gene name forward primer, 5-3 probe, 5-3 reverse primer,
More informationHuman Urokinase / PLAU / UPA ELISA Pair Set
Human Urokinase / PLAU / UPA ELISA Pair Set Catalog Number : SEK10815 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized
More informationA Hepatocyte Growth Factor Receptor (Met) Insulin Receptor hybrid governs hepatic glucose metabolism SUPPLEMENTARY FIGURES, LEGENDS AND METHODS
A Hepatocyte Growth Factor Receptor (Met) Insulin Receptor hybrid governs hepatic glucose metabolism Arlee Fafalios, Jihong Ma, Xinping Tan, John Stoops, Jianhua Luo, Marie C. DeFrances and Reza Zarnegar
More informationInterest in any of the products, request or order them at Bio-Connect Diagnostics.
M3 CytoDEATH ELISA Interest in any of the products, request or order them at Bio-Connect Diagnostics. Bio-Connect Diagnostics B.V. T NL +31 ()26 326 44 6 T BE +32 ()2 52 12 53 Begonialaan 3a F NL +31 ()26
More informationMammalian Tissue Protein Extraction Reagent
Mammalian Tissue Protein Extraction Reagent Catalog number: AR0101 Boster s Mammalian Tissue Protein Extraction Reagent is a ready-to-use Western blot related reagent solution used for efficient extraction
More information2,6,9-Triazabicyclo[3.3.1]nonanes as overlooked. amino-modification products by acrolein
Supplementary Information 2,6,9-Triazabicyclo[3.3.1]nonanes as overlooked amino-modification products by acrolein Ayumi Tsutsui and Katsunori Tanaka* Biofunctional Synthetic Chemistry Laboratory, RIKEN
More informationBMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice
SUPPLEMENTARY MATERIALS BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice Elena Corradini, Paul J. Schmidt, Delphine Meynard, Cinzia Garuti, Giuliana
More informationECL Plex Western Blotting Detection System
Part of GE Healthcare Data File 28-415-39 AA ECL Plex Western Blotting Detection System Multiplex protein detection based on direct fluorescent CyDye-labeled conjugates ECL Plex fluorescent Western blotting
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION FOR Liver X Receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 (G0S2) expression I: SUPPLEMENTARY METHODS II: SUPPLEMENTARY FIGURES
More informationRNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using
Supplementary Information Materials and Methods RNA extraction, RT-PCR and real-time PCR. Total RNA were extracted using Trizol reagent (Invitrogen,Carlsbad, CA) according to the manufacturer's instructions.
More informationSTUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS
STUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS Xiannu Jin 1, Radharaman Ray 2, Guang Xu 1 and Prabhati Ray 1 1 Department
More informationSerum Amyloid A3 Gene Expression in Adipocytes is an Indicator. of the Interaction with Macrophages
Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator of the Interaction with Macrophages Yohei Sanada, Takafumi Yamamoto, Rika Satake, Akiko Yamashita, Sumire Kanai, Norihisa Kato, Fons AJ van
More informationData Sheet. PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002
Data Sheet PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002 DESCRIPTION: The PCSK9[Biotinylated]-LDLR Binding Assay Kit is designed for screening and profiling purposes. PCSK9 is known to function
More informationSupplementary Data Table of Contents:
Supplementary Data Table of Contents: - Supplementary Methods - Supplementary Figures S1(A-B) - Supplementary Figures S2 (A-B) - Supplementary Figures S3 - Supplementary Figures S4(A-B) - Supplementary
More informationSupplementary Materials and Methods
Supplementary Materials and Methods Immunoblotting Immunoblot analysis was performed as described previously (1). Due to high-molecular weight of MUC4 (~ 950 kda) and MUC1 (~ 250 kda) proteins, electrophoresis
More informationRayBio Human Phospho-DDR2 (Tyr740) and Total DDR2 ELISA Kit
RayBio Human Phospho-DDR2 (Tyr740) and Total DDR2 ELISA Kit Catalog #: PEL-DDR2-Y740-T User Manual Last revised March 22, 2018 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607
More informationCathepsin K Activity Assay Kit
Cathepsin K Activity Assay Kit Catalog Number KA0769 100 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4 Materials
More informationInfluenza B Hemagglutinin / HA ELISA Pair Set
Influenza B Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK11053 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized
More informationGLP-2 (Rat) ELISA. For the quantitative determination of glucagon-like peptide 2 (GLP-2) in rat serum and plasma
GLP-2 (Rat) ELISA For the quantitative determination of glucagon-like peptide 2 (GLP-2) in rat serum and plasma For Research Use Only. Not For Use In Diagnostic Procedures. Catalog Number: 48-GP2RT-E01
More informationEGFR (py1045)/ Pan EGFR (Human) ELISA Kit
EGFR (py1045)/ Pan EGFR (Human) ELISA Kit Catalog Number KA2156 96 assays Version: 01 Intended for research use only www.abnova.com I. INTRODUCTION EGFR (py1045)/pan EGFR (Human) ELISA (Enzyme-Linked Immunosorbent
More informationInfluenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set
Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay
More informationSensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric*
SensoLyte pnpp Alkaline Phosphatase Assay Kit *Colorimetric* Catalog # 72146 Kit Size 500 Assays (96-well plate) Optimized Performance: This kit is optimized to detect alkaline phosphatase activity Enhanced
More informationExosome ELISA Complete Kits
Exosome ELISA Complete Kits EXOEL-CD9A-1, EXOEL-CD63A-1, EXOEL-CD81A-1 User Manual See PAC for Storage Conditions for Individual Components Version 12 4/17/2017 A limited-use label license covers this
More informationSupplementary material: Materials and suppliers
Supplementary material: Materials and suppliers Electrophoresis consumables including tris-glycine, acrylamide, SDS buffer and Coomassie Brilliant Blue G-2 dye (CBB) were purchased from Ameresco (Solon,
More informationHuman LDL Receptor / LDLR ELISA Pair Set
Human LDL Receptor / LDLR ELISA Pair Set Catalog Number : SEK10231 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in
More informationEffec<ve Use of PI3K and MEK Inhibitors to Treat Mutant K Ras G12D and PIK3CA H1047R Murine Lung Cancers
Effec
More information2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit
2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as
More informationphospho-insulin Receptor b Subunit (ptyr 1158 ) ELISA Catalog Number PI0100 Storage Temperature 2-8 C Technical Bulletin
phospho-insulin Receptor b Subunit (ptyr 1158 ) ELISA Catalog Number PI0100 Storage Temperature 2-8 C Technical Bulletin Product Description phospho-insulin Receptor β Subunit (ptyr 1158 ) ELISA is a solid
More informationRayBio Human Phospho-DDR1 (Tyr792) ELISA Kit
RayBio Human Phospho-DDR1 (Tyr792) ELISA Kit Catalog #: PEL-DDR1-Y792 User Manual Last revised March 22, 2018 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane,
More informationRayBio Human Phospho-DDR1 (Tyr792) and Total DDR1 ELISA Kit
RayBio Human Phospho-DDR1 (Tyr792) and Total DDR1 ELISA Kit Catalog #: PEL-DDR1-Y792-T User Manual Last revised March 22, 2018 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607
More informationhuman Total Cathepsin B Catalog Number: DY2176
human Total Cathepsin B Catalog Number: DY2176 This DuoSet ELISA Development kit contains the basic components required for the development of sandwich ELISAs to measure natural and recombinant human Total
More informationAmersham ECL Prime Western blotting reagent
GE Healthcare Life Sciences Data file 28-9857-23 AA Western blotting reagents Amersham ECL Prime Western blotting reagent Since its introduction in 199, the enhanced chemiluminescence (ECL) Western Blotting
More informationSupplementary Figure 1 Role of Raf-1 in TLR2-Dectin-1-mediated cytokine expression
Supplementary Figure 1 Supplementary Figure 1 Role of Raf-1 in TLR2-Dectin-1-mediated cytokine expression. Quantitative real-time PCR of indicated mrnas in DCs stimulated with TLR2-Dectin-1 agonist zymosan
More informationSupporting Information
Supporting Information Identification of Novel ROS Inducers: Quinone Derivatives Tethered to Long Hydrocarbon Chains Yeonsun Hong,, Sandip Sengupta,, Wooyoung Hur, *, Taebo Sim,, * KU-KIST Graduate School
More informationAssay Report. Histone Deacetylase (HDAC) Inhibitor Assays Enzymatic Study of Compounds from Client
Assay Report Histone Deacetylase (HDAC) Inhibitor Assays Enzymatic Study of Compounds from Client Page 1 of 27 Client_HDAC _Year Month Day 1 Client_HDAC_Year Month Year HDAC Inhibitor Assays Study Sponsor:
More information20X Buffer (Tube1) 96-well microplate (12 strips) 1
PROTOCOL MitoProfile Rapid Microplate Assay Kit for PDH Activity and Quantity (Combines Kit MSP18 & MSP19) 1850 Millrace Drive, Suite 3A Eugene, Oregon 97403 MSP20 Rev.1 DESCRIPTION MitoProfile Rapid Microplate
More informationSupplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were
Supplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were isolated from wild type (PKC-θ- WT) or PKC-θ null (PKC-θ-KO)
More informationAMPK Phosphorylation Assay Kit
AMPK Phosphorylation Assay Kit Catalog Number KA3789 100 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationProteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival
Supplementary Information for Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival Tatsuro Kawamura 1, Makoto Kawatani 1, Makoto Muroi, Yasumitsu Kondoh,
More informationIMMP8-1. Different Mechanisms of Androg and IPAD on Apoptosis Induction in Cervical Cancer Cells
IMMP8-1 Different Mechanisms of Androg and IPAD on Apoptosis Induction in Cervical Cancer Cells Assanan Dokmaikaew* Tipaya Ekalaksananan** Dr.Chamsai Pientong** ABSTRACT Androg and IPAD are recently known
More informationSupporting Online Material Material and Methods References Supplemental Figures S1, S2, and S3
Supporting Online Material Material and Methods References Supplemental Figures S1, S2, and S3 Sarbassov et al. 1 Material and Methods Materials Reagents were obtained from the following sources: protein
More informationExosome ELISA Complete Kits
Exosome ELISA Complete Kits EXOEL-CD9A-1, EXOEL-CD63A-1, EXOEL-CD81A-1 User Manual See PAC for Storage Conditions for Individual Components Version 12 4/17/2017 A limited-use label license covers this
More informationWestern Immunoblotting Preparation of Samples:
Western Immunoblotting Preparation of Samples: Total Protein Extraction from Culture Cells: Take off the medium Wash culture with 1 x PBS 1 ml hot Cell-lysis Solution into T75 flask Scrap out the cells
More informationA549 and A549-fLuc cells were maintained in high glucose Dulbecco modified
Cell culture and animal model A549 and A549-fLuc cells were maintained in high glucose Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum at 37 C in humidified atmosphere containing
More informationInfluenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set
Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK40103 To achieve the best assay results, this manual must be read carefully before using this product and the assay
More information